150 Mg Olaparib Tablets

Name: 150 Mg Olaparib Tablets
Brand: NEETCO BIOPHARMA
Price: 7500 INR
Availability: InStock

Price 7500 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

150 Mg Olaparib Tablets Specification

Indication
Treatment of ovarian, breast, pancreatic, and prostate cancer; indicated for patients with specific BRCA mutations

Salt Composition
Olaparib 150 mg

Dosage Form
Tablet

Enzyme Types
PARP (Poly ADP-Ribose Polymerase) inhibitor

Feature
High efficacy in BRCA-mutated cancers; targeted mechanism of action; well-tolerated

Ingredients
Olaparib, excipients (including stabilizers, fillers, binders, and film-coating agents)

Application
Oral administration for cancer therapy

Physical Color/Texture
Green, oval-shaped film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits PARP enzyme activity

Storage Instructions
Store below 30C, in original packaging, away from moisture and light

Shelf Life
24 months from the date of manufacture

About 150 Mg Olaparib Tablets

Buy the ultimate 150 mg Olaparib Tablets, an unrivaled choice for targeted cancer therapy. Offered at an affordable list price, our cost-effective tablets are available in convenient alu-alu or blister packs and come in strips of 7, 14, or 30, designed for prescription-only use. Approved by trusted regulatory authorities like the US FDA and EMA, each green, oval tablet delivers enviable efficacy, particularly in BRCA-mutated cancers. As a leading distributor, exporter, and supplier in India, we guarantee quality, rigorous safety, and a 24-month shelf life. Stock is always ready for prompt dispatch.

Commercial Applications & Key Features of 150 mg Olaparib Tablets

150 mg Olaparib Tablets offer a cost-effective and targeted solution for adult patients with ovarian, breast, pancreatic, or prostate cancers featuring specific BRCA mutations. The film-coated, green oval tablets utilize surface oral administration, maximizing PARP enzyme inhibition for enviable clinical outcomes. These tablets exhibit high efficacy and are well-tolerated, with versatile packaging options, making them ideal for robust commercial distribution across healthcare sectors. The odorless formulation ensures patient-friendly use and storage simplicity.

Sample Policy and Main Domestic Market for Olaparib Tablets

Stock ready for immediate packing & dispatch is available as per industry standards. 150 mg Olaparib Tablets samples can be provided upon request, allowing for market testing and clinical evaluation at competitive list prices. We cater to the main domestic market in India, ensuring swift delivery and responsive customer support. Flexible packing options and export capabilities allow easy access to healthcare facilities nationwide, reinforcing trust with both distributors and medical professionals.

FAQ's of 150 Mg Olaparib Tablets:

Q: How do 150 mg Olaparib Tablets function in cancer therapy?

A: 150 mg Olaparib Tablets act as PARP inhibitors, blocking PARP enzyme activity to promote targeted destruction of cancer cells, especially beneficial for patients with BRCA gene mutations.

Q: What are the available packing sizes and packaging types for Olaparib Tablets?

A: Olaparib Tablets are supplied in alu-alu or blister packs, available in strips containing 7, 14, or 30 tablets for flexible dosing and convenience.

Q: When should Olaparib Tablets be used, and for which conditions?

A: Olaparib Tablets are indicated for adult patients managing ovarian, breast, pancreatic, or prostate cancers, specifically for those with confirmed BRCA mutations and under prescription supervision.

Q: Where can I purchase Olaparib Tablets and are samples available?

A: Olaparib Tablets can be bought from authorized distributors, exporters, and suppliers across India, with samples available upon request to registered healthcare professionals and facilities.

Q: How is the packing and dispatch process managed for orders?

A: We maintain stock ready for rapid packing and dispatch, ensuring each order is securely packed according to regulatory and customer requirements, with prompt delivery across domestic markets.

Q: What precautions should be observed while using Olaparib Tablets?

A: Regular monitoring of renal and hepatic function is advised. These tablets should not be used during pregnancy or breastfeeding, or in patients hypersensitive to Olaparib or its components.

Tell us about your requirement